SCHEMBL18801286

SCHEMBL18801286

COc1c(-c2cnsc2)ccc(CSc2ccccc2)c1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC37A4 O43826 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
KMT2A Q03164 4/20 0.35
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 5/20 0.32
NPSR1 Q6W5P4 2/20 0.32
PABPC1 P11940 1/20 0.32
GAA P10253 1/20 0.32
MEN1 O00255 3/20 0.32
PKM P14618 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 2/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18801059 0.85 KMT2A (0.42) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18801055 0.83 SLC37A4 (0.38) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL1649341 0.81 METAP2 (0.47) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL1648035 0.80 KEAP1 (0.38) L3MBTL1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL18801149 0.80 L3MBTL1 (0.39) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18801417 0.76 KMT2A (0.44) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18801282 0.75 KMT2A (0.43) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18801057 0.75 METAP2 (0.42) KMT2ANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18801293 0.75 KMT2A (0.45) SLC37A4L3MBTL1KMT2ANPC1RAB9A
SCHEMBL18801404 0.74 KMT2A (0.38) SLC37A4L3MBTL1KMT2ANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2486004-B1 SULPHONE COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY ZAFGEN INC (US) 2017-05-03 EP disclosed